Scientific instrument company Bruker (NASDAQ:BRKR). reported Q4 CY2024 results , with sales up 14.6% year on year to $979.6 ...

Scientific instrument company Bruker (NASDAQ:BRKR). will be reporting results tomorrow before market hours. Here’s what ...

In a report released today, Michael Ryskin from Bank of America Securities maintained a Buy rating on Bruker (BRKR – Research Report). The ...

Barclays analyst Luke Sergott maintained a Buy rating on Bruker (BRKR – Research Report) today and set a price target of $60.00. The company’s ...

Frank Laukien; Chairman of the Board, President, Chief Executive Officer; Bruker Corp Gerald Herman; Chief Financial Officer, Executive Vice President; Bruker Corp Good day, and welcome to the Bruker ...

Bruker Corp (BRKR) reports a 14.6% increase in Q4 revenue and sets optimistic guidance for 2025 despite challenges in Asia ...

Bruker expects full-year earnings in the range of $2.67 to $2.72 per share, with revenue in the range of $3.47 billion to $3.54 billion. Bruker shares have fallen 12% since the beginning of the year.

Souda now anticipates that the medical research company will post earnings of $2.39 per share for the year, up from their previous forecast of $2.38. The consensus estimate for Bruker’s current ...

The company operates mainly under two operating segments; Its Bruker Scientific Instrument ("BSI") segment, which includes BSI BioSpin, BSI CALID, BSI NANO and its Bruker Energy & Supercon Tech ...

Bruker (NASDAQ:BRKR – Get Free Report) had its price target lowered by stock analysts at Barclays from $69.00 to $65.00 in a research note issued on Monday,Benzinga reports. The firm currently has an ...